Tokyo Tape
Sign in
← PHC Holdings

Half-year report · Q2

6523.TEDINET S100UR3H
Period2024-04-01 → 2024-09-30
Filed2024-11-13
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥173.9bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Revenue¥353.9bn2023-04-01 → 2024-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥166.8bn2023-04-01 → 2023-09-30Cons.Revenue IFRS
Operating income¥9.2bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Operating income¥4.2bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Profit before tax¥7.4bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥13.2bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥3.0bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥4.1bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥12.9bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥2.5bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥4.0bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Net income−¥2.4bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Total assets¥525.4bnat 2024-09-30Cons.Assets IFRS
Total assets¥564.3bnat 2024-03-31Cons.Assets IFRS
Total assets¥570.4bnat 2023-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥398.0bnat 2024-09-30Cons.Liabilities IFRS
Total liabilities¥425.2bnat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥127.4bnat 2024-09-30Cons.Equity IFRS
Net assets / equity¥139.2bnat 2024-03-31Cons.Equity IFRS
Net assets / equity¥147.0bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥138.8bnat 2023-03-31dCons.Equity IFRS
Equity (owners)¥127.8bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥139.5bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥147.4bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥33.0bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥47.0bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥61.4bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.9bnat 2023-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥13.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥41.3bn2023-04-01 → 2024-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥22.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥5.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥21.1bn2023-04-01 → 2024-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥2.1bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥20.9bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥39.1bn2023-04-01 → 2024-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥23.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥32.522024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-102.482023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-19.552023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥32.422024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-102.482023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-19.552023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio24.3%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.7%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio25.8%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30¥1.6bn
Reconciling Itemsreconcilingrevenue external2024-04-01 → 2024-09-30¥1.6bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥4.3bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentrevenue2024-04-01 → 2024-09-30¥48.3bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentrevenue external2024-04-01 → 2024-09-30¥48.3bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentsegment profit2024-04-01 → 2024-09-30¥6.4bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2024-04-01 → 2024-09-30¥62.6bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2024-04-01 → 2024-09-30¥62.6bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2024-04-01 → 2024-09-30¥3.5bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentrevenue2024-04-01 → 2024-09-30¥61.5bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentrevenue external2024-04-01 → 2024-09-30¥61.5bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentsegment profit2024-04-01 → 2024-09-30¥3.6bn
—segment totalrevenue2024-04-01 → 2024-09-30¥172.3bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥172.3bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥13.5bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30¥1.1bn
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-09-30¥1.1bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥4.8bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentrevenue2023-04-01 → 2023-09-30¥48.8bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentrevenue external2023-04-01 → 2023-09-30¥48.8bn
jpcrp040300-q2r_E36976-000Diabetes Managementreportable segmentsegment profit2023-04-01 → 2023-09-30¥5.5bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2023-04-01 → 2023-09-30¥61.0bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2023-04-01 → 2023-09-30¥61.0bn
jpcrp040300-q2r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2023-04-01 → 2023-09-30¥2.5bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentrevenue2023-04-01 → 2023-09-30¥55.9bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentrevenue external2023-04-01 → 2023-09-30¥55.9bn
jpcrp040300-q2r_E36976-000Healthcare Solutionsreportable segmentsegment profit2023-04-01 → 2023-09-30¥951m
—segment totalrevenue2023-04-01 → 2023-09-30¥165.7bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥165.7bn
—segment totalsegment profit2023-04-01 → 2023-09-30¥8.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 812
ItemContextValueUnit
Share capital IFRSPrior1YearInstant48423000000JPY
Share capital IFRSCurrentQuarterInstant48522000000JPY
Capital surplus IFRSPrior1YearInstant41797000000JPY
Capital surplus IFRSCurrentQuarterInstant41802000000JPY
Retained earnings IFRSPrior1YearInstant-2773000000JPY
Retained earnings IFRSCurrentQuarterInstant-1841000000JPY
Treasury shares IFRSPrior1YearInstant-568000000JPY
Treasury shares IFRSCurrentQuarterInstant-568000000JPY
Other components of equity IFRSPrior1YearInstant52635000000JPY
Other components of equity IFRSCurrentQuarterInstant39887000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant139515000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant127803000000JPY
Non controlling interests IFRSPrior1YearInstant-351000000JPY
Non controlling interests IFRSCurrentQuarterInstant-413000000JPY
Equity IFRSPrior1YearInstant139163000000JPY
Equity IFRSCurrentQuarterInstant127389000000JPY
Liabilities and equity IFRSPrior1YearInstant564327000000JPY
Liabilities and equity IFRSCurrentQuarterInstant525436000000JPY
Revenue IFRSPrior1YTDDuration166819000000JPY
Revenue IFRSCurrentYTDDuration173863000000JPY
Cost of sales IFRSPrior1YTDDuration91728000000JPY
Cost of sales IFRSCurrentYTDDuration92635000000JPY
Gross profit IFRSPrior1YTDDuration75090000000JPY
Gross profit IFRSCurrentYTDDuration81227000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration71390000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration72071000000JPY
Other income IFRSPrior1YTDDuration2989000000JPY
Other income IFRSCurrentYTDDuration384000000JPY
Other expenses IFRSPrior1YTDDuration2368000000JPY
Other expenses IFRSCurrentYTDDuration166000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration-138000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration-162000000JPY
Operating profit loss IFRSPrior1YTDDuration4182000000JPY
Operating profit loss IFRSCurrentYTDDuration9212000000JPY
Finance income IFRSPrior1YTDDuration463000000JPY
Finance income IFRSCurrentYTDDuration1414000000JPY
Finance costs IFRSPrior1YTDDuration7675000000JPY
Finance costs IFRSCurrentYTDDuration3215000000JPY
Profit loss before tax IFRSPrior1YTDDuration-3030000000JPY
Profit loss before tax IFRSCurrentYTDDuration7411000000JPY
Income tax expense IFRSPrior1YTDDuration-614000000JPY
Income tax expense IFRSCurrentYTDDuration3389000000JPY
Profit loss IFRSPrior1YTDDuration-2415000000JPY
Profit loss IFRSCurrentYTDDuration4022000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration-2457000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration4100000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration41000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration-78000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration-19.55
Basic earnings loss per share IFRSCurrentYTDDuration32.52

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass